Prediction of cancer driver genes and mutations: the potential of integrative computational frameworks
Briefings in Bioinformatics · 22.01.2024 · 25 (2)
DOI: 10.1093/bib/bbad519 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Briefings in Bioinformatics, online erschienen am 22.01.2024. Verfasst von Mona Nourbakhsh und 4 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Systems Biology, Section for Bioinformatics, Department of Health Technology, Technical University of Denmark, 2800 Lyngby, Denmark. Hauptthemen laut MEDLINE: Neoplasms, Oncogenes. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 156 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Hartmanns Fond, LEO Fondet, Carlsberg Foundation Distinguished Fellowship.
Abstract (Originalsprache)
The vast amount of available sequencing data allows the scientific community to explore different genetic alterations that may drive cancer or favor cancer progression. Software developers have proposed a myriad of predictive tools, allowing researchers and clinicians to compare and prioritize driver genes and mutations and their relative pathogenicity. However, there is little consensus on the computational approach or a golden standard for comparison. Hence, benchmarking the different tools depends highly on the input data, indicating that overfitting is still a massive problem. One of the solutions is to limit the scope and usage of specific tools. However, such limitations force researchers to walk on a tightrope between creating and using high-quality tools for a specific purpose and describing the complex alterations driving cancer. While the knowledge of cancer development increases daily, many bioinformatic pipelines rely on single nucleotide variants or alterations in a vacuum without accounting for cellular compartments, mutational burden or disease progression. Even within bioinformatics and computational cancer biology, the research fields work in silos, risking overlooking potential synergies or breakthroughs. Here, we provide an overview of databases and datasets for building or testing predictive cancer driver tools. Furthermore, we introduce predictive tools for driver genes, driver mutations, and the impact of these based on structural analysis. Additionally, we suggest and recommend directions in the field to avoid silo-research, moving towards integrative frameworks.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cancer Systems Biology, Section for Bioinformatics, Department of Health Technology, Technical University of Denmark, 2800 Lyngby, Denmark.
- Cancer Structural Biology, Danish Cancer Institute, 2100 Copenhagen, Denmark.
Förderung
- Hartmanns Fond
- LEO Fondet
- Carlsberg Foundation Distinguished Fellowship
- NovoNordisk Fonden Bioscience and Basic Biomedicine
- Center of Excellence in Autophagy, Recycling and Disease
- Danish National Research Foundation
Zitieren
APA
Nourbakhsh, M., Degn, K., Saksager, A., Tiberti, M., & Papaleo, E. (2024). Prediction of cancer driver genes and mutations: the potential of integrative computational frameworks. Briefings in Bioinformatics, 25(2). https://doi.org/10.1093/bib/bbad519
Vancouver
Nourbakhsh M, Degn K, Saksager A, Tiberti M, Papaleo E. Prediction of cancer driver genes and mutations: the potential of integrative computational frameworks. Briefings in Bioinformatics. 2024;25(2). doi:10.1093/bib/bbad519
BibTeX
@article{Nourbakhsh2024,
author = {Nourbakhsh, Mona and Degn, Kristine and Saksager, Astrid and Tiberti, Matteo and Papaleo, Elena},
title = {Prediction of cancer driver genes and mutations: the potential of integrative computational frameworks},
journal = {Briefings in Bioinformatics},
year = {2024},
volume = {25},
number = {2},
doi = {10.1093/bib/bbad519}
}
EUVIMED